Dengue, chikungunya may soon be endemic in Europe
25 May 2025 08:00pm
Photo for illustration purpose only. - File photo by Bernama
PARIS - The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these viruses spread farther north due to global warming, according to new research published recently.
Roughly half the world's population is already at risk of contracting the two diseases, which were once mainly confined to tropical regions. Photo for illustrative purposes only - 123RF photo
Both viruses cause fevers and can be deadly in rare cases, spread by the mosquitoes Aedes aegypti and Aedes albopictus.
The latter, which is known as the tiger mosquito, is venturing further north as the world warms because of human-driven climate change.
The new study, published in the Lancet Planetary Health journal, analyses the impact a number of factors including the climate have had on the spread of the two diseases in Europe over the last 35 years.
The frequency and severity of outbreaks have increased since 2010 as temperatures have risen, according to the study.
Yet just over 300 cases of dengue were recorded in the European Union in 2024 -- the hottest year on record -- compared to 275 over the previous 15 years.
Dengue outbreaks have now hit Italy, Croatia, France and Spain.
"Our findings highlight that the EU is transitioning from sporadic outbreaks of Aedes-borne diseases towards an endemic state," it said.
The higher temperatures soar, the greater the risk of outbreaks caused by tiger mosquitoes, the European research team said.
Under worst-case climate change scenarios, outbreaks of both diseases could rise to five times the current rate by 2060, they projected.
Outbreaks have been more common in wealthier areas, suggesting that better testing is able to spot the virus -- and that cases could be going undetected in poorer areas, the study suggested.
The French Indian Ocean island of Reunion has recently endured a deadly outbreak of chikungunya.
Tiger mosquitoes can also transmit the zika and West Nile viruses, which were not studied in the latest research. - AFP
More Like This
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Barnama
37 minutes ago
- Barnama
Dr Falk Pharma, Allianthera Partner To Develop Novel AhR Agonist
KUALA LUMPUR, July 30 (Bernama) -- Dr Falk Pharma GmbH and Allianthera have announced a strategic agreement to co-develop and commercialise ATB102, an aryl hydrocarbon receptor (AhR) agonist currently in Phase 1 trials in the United States. The partnership aims to advance ATB102 as a new treatment for refractory moderate-to-severe ulcerative colitis (UC) and potentially broader inflammatory bowel disease (IBD) indications, according to a statement. Under the deal, Dr Falk Pharma gains exclusive global rights, excluding Mainland China, Hong Kong, Macau, and Taiwan, to license, manufacture, and commercialise ATB102. In return, Allianthera will receive upfront fees, development and sales milestone payments, and tiered royalties.
Barnama
4 hours ago
- Barnama
MoH Stands By Educational Enforcement Of Medicine Price Display Regulation
GENERAL PUTRAJAYA, July 30 (Bernama) — The Ministry of Health (MOH) will continue focusing on education and awareness in enforcing the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025, despite a pending judicial review application challenging the regulation. Health Minister Datuk Seri Dr Dzulkefly Ahmad said the ministry respects the legal process but is committed to ensuring smooth implementation of the order through educational enforcement. 'We will continue with this approach to avoid enforcement gaps while the court process is ongoing,' he told reporters after officiating the 2025 National Health Technology Assessment Conference and the 30th anniversary of the Malaysian Health Technology Assessment Section (MaHTAS) here today. The regulation, which came into force on May 1, mandates all private clinics and community pharmacies to display medicine prices on shelves, in catalogues or on written price lists, under the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025. Dr Dzulkefly was responding to reports that the Malaysian Medical Association (MMA) and seven other organisations have applied for leave to initiate a judicial review of the order. Among the applicants are the Sabah Private Practitioners Association (APPS), the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine (MAAFIM), the Malaysian Muslim Doctors Association (PERDIM), and the Federation of Private Medical Practitioners' Associations Malaysia (FPMPAM). On May 4, Dr Dzulkefly had clarified that no fines or compounds would be issued during the first three months of enforcement, as the ministry's priority was on stakeholder education. As of now, neither MOH nor the Ministry of Domestic Trade and Cost of Living (KPDN) has announced an extension to the grace period, which ends tomorrow (July 31). -- BERNAMA
Barnama
4 hours ago
- Barnama
MoH Open To Reclassifying Etomidate Under Dangerous Drugs Act
PUTRAJAYA, July 30 (Bernama) -- The Health Ministry (MoH) is open to reviewing the proposal to list 'etomidate' under the Dangerous Drugs Act 1952 following reports of its frequent abuse, its minister Datuk Seri Dr Dzulkefly Ahmad said. He said that based on current clinical practices, the MoH is always ready to carry out evaluations or studies based on evidence presented by any party. Etomidate is currently listed under the Poisons Act 1952. 'Any proposal can be considered, but at the end of the day, I look at the evidence base when evaluating something,' he told a press conference after officiating the 2025 National Health Technology Assessment Conference and the 30th Anniversary Celebration of the Health Technology Assessment Section (MaHTAS) here today. Bandar Kuching MP Dr Kelvin Yii had before this urged the government to list etomidate under both the Poisons Act 1952 and the Dangerous Drugs Act 1952, citing reports of its fatal effects in Singapore. He said etomidate is an intravenous anaesthetic that has been misused as a recreational substance through vape products, often marketed as 'Kpods'. Kpods is a street term that usually refers to vape pods laced or contaminated with harmful chemicals or synthetic drugs, rather than just regular vape liquids like nicotine or flavoring. In a related development, Dzulkefly said the government is currently reviewing a proposal to ban e-cigarettes or vapes in the country. 'I'm taking note, but I don't want to act hastily. We are taking this very seriously, and it needs to go through a thorough evaluation and consideration of legal and public health impacts,' he said.
